Literature DB >> 24779032

Ambulatory quality indicators to prevent infection in sickle cell disease.

Lauren M Beverung, David Brousseau, Raymond G Hoffmann, Ke Yan, Julie A Panepinto.   

Abstract

The purpose of this study was to identify rates of adherence for three outpatient quality indicators noted by Wang et al. (Pediatrics 2011;128:484–493): (1) influenza vaccine, (2) pneumococcal immunizations, and (3)penicillin prophylaxis in patients with sickle cell disease (SCD) in a Medicaid sample. These variables were chosen based on Wang and colleagues' suggestion that these variables are important for the assessment of the quality of care of children with SCD. We hypothesized that the overall rate of adherence would be poor with adults having worse rates of adherence than children. We conducted a retrospective cohort study using the Wisconsin State Medicaid database over a 5-year period to assess the preventative medication adherence of individuals with SCD. Preventative medication variables in this study included influenza vaccination,pneumococcal immunizations (PCV7, PPV23), and penicillin prophylaxis. As predicted, the 2003–2007 Wisconsin State Medicaid database showed patients with SCD had low adherence in terms of recommended influenza vaccinations (21.58% adherent), PPV23 pneumococcal immunizations (43.47% adherent), and penicillin prophylaxis (18.18% adherent). Pneumococcal immunizations for PCV7 were higher than expected (77.27%adherent). Although children tended to adhere to recommended preventative medications more than adults,overall adherence was low. Although we cannot explain why adherence is low, it is likely due to multiple factors at the patient- and provider-level. We encourage patients and providers to create a partnership to meet adherence recommendations, and we describe our strategies for increasing adherence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24779032      PMCID: PMC4450348          DOI: 10.1002/ajh.23627

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  23 in total

1.  Sickle cell disease-related pediatric medical expenditures in the U.S.

Authors:  Djesika D Amendah; Mercy Mvundura; Patricia L Kavanagh; Philippa G Sprinz; Scott D Grosse
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

2.  The association of health insurance and continuous primary care in the medical home on vaccination coverage for 19- to 35-month-old children.

Authors:  Norma J Allred; Karen G Wooten; Yuan Kong
Journal:  Pediatrics       Date:  2007-02       Impact factor: 7.124

3.  The number of people with sickle-cell disease in the United States: national and state estimates.

Authors:  David C Brousseau; Julie A Panepinto; Mark Nimmer; Raymond G Hoffmann
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

4.  Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis.

Authors:  Niti G Patel; Terianne Lindsey; Robert C Strunk; Michael R DeBaun
Journal:  Pediatr Blood Cancer       Date:  2010-09       Impact factor: 3.167

5.  Adherence to prophylactic antibiotic guidelines among Medicaid infants with sickle cell disease.

Authors:  Michael D Warren; Patrick G Arbogast; Judy A Dudley; Lisa Kaltenbach; Wayne A Ray; Winfred C Wang; William O Cooper
Journal:  Arch Pediatr Adolesc Med       Date:  2010-03

6.  Medical care utilization and mortality in sickle cell disease: a population-based study.

Authors:  Sadhna M Shankar; Patrick G Arbogast; Ed Mitchel; William O Cooper; Winfred C Wang; Marie R Griffin
Journal:  Am J Hematol       Date:  2005-12       Impact factor: 10.047

7.  Spatial accessibility to providers and vaccination compliance among children with medicaid.

Authors:  Linda Y Fu; Nuala Cowan; Rosie McLaren; Ryan Engstrom; Stephen J Teach
Journal:  Pediatrics       Date:  2009-11-23       Impact factor: 7.124

8.  An audit of immunisation status of sickle cell patients in Coventry, UK.

Authors:  M Howard-Jones; L Randall; B Bailey-Squire; J Clayton; N Jackson
Journal:  J Clin Pathol       Date:  2009-01       Impact factor: 3.411

9.  Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.

Authors:  Amanda B Payne; Ruth Link-Gelles; Ijeoma Azonobi; W Craig Hooper; Bernard W Beall; James H Jorgensen; Billie Juni; Matthew Moore
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

10.  Impact of family income and sickle cell disease on the health-related quality of life of children.

Authors:  Julie A Panepinto; Nicholas M Pajewski; Lisa M Foerster; Svapna Sabnis; Raymond G Hoffmann
Journal:  Qual Life Res       Date:  2008-11-07       Impact factor: 4.147

View more
  19 in total

1.  Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease.

Authors:  Robert M Cronin; Manshu Yang; Jane S Hankins; Jeannie Byrd; Brandi M Pernell; Adetola Kassim; Patricia Adams-Graves; Alexis A Thompson; Karen Kalinyak; Michael DeBaun; Marsha Treadwell
Journal:  Hematology       Date:  2020-12       Impact factor: 2.269

2.  Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.

Authors:  Jin Han; Shubha Bhat; Michel Gowhari; Victor R Gordeuk; Santosh L Saraf
Journal:  Pharmacotherapy       Date:  2016-10-03       Impact factor: 4.705

Review 3.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

4.  Antibiotic Prophylaxis for Children With Sickle Cell Anemia.

Authors:  Sarah L Reeves; Alison C Tribble; Brian Madden; Gary L Freed; Kevin J Dombkowski
Journal:  Pediatrics       Date:  2018-02-05       Impact factor: 7.124

5.  Hydroxyurea Initiation Among Children With Sickle Cell Anemia.

Authors:  Sarah L Reeves; Hannah K Jary; Jennifer P Gondhi; Jean L Raphael; Lynda D Lisabeth; Kevin J Dombkowski
Journal:  Clin Pediatr (Phila)       Date:  2019-05-21       Impact factor: 1.168

6.  Determining Adherence to Quality Indicators in Sickle Cell Anemia Using Multiple Data Sources.

Authors:  Cindy E Neunert; Robert W Gibson; Peter A Lane; Pragya Verma-Bhatnagar; Vaughn Barry; Mei Zhou; Angela Snyder
Journal:  Am J Prev Med       Date:  2016-07       Impact factor: 5.043

Review 7.  Rigorous and practical quality indicators in sickle cell disease care.

Authors:  Suzette O Oyeku; Elissa Z Faro
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

8.  Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic.

Authors:  Chung-Jen Chen; Sabrina Bakeera-Kitaka; Ezekiel Mupere; Philip Kasirye; Deogratias Munube; Richard Idro; Heather Hume; Betsy Pfeffer; Philip LaRussa; Nancy S Green
Journal:  J Paediatr Child Health       Date:  2018-11-09       Impact factor: 1.954

9.  Influenza vaccine effectiveness and disease burden in children and adolescents with sickle cell disease: 2012-2017.

Authors:  Carol M Kao; Kristina Lai; John M McAteer; Mohnd Elmontser; Elizabeth M Quincer; Marianne E M Yee; Ashley Tippet; Robert C Jerris; Peter A Lane; Evan J Anderson; Nitya Bakshi; Inci Yildirim
Journal:  Pediatr Blood Cancer       Date:  2020-05-29       Impact factor: 3.167

10.  Preventive Care Delivery to Young Children With Sickle Cell Disease.

Authors:  David G Bundy; John Muschelli; Gwendolyn D Clemens; John J Strouse; Richard E Thompson; James F Casella; Marlene R Miller
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.